BG PHARMACEUTICAL is committed to the Life Sciences with continued research for the development of treatments and cures for currently incurable skin diseases and innovative Inflammation Treatment issues.

BG PHARMACEUTICAL’s core patented technology is SPM™ BG PHARMACEUTICAL has acquired the original technology patent for base substances in Korea (2017) and the USA (2020).

SPM™ produces excellent results in the treatment of chronic skin diseases and wounds.

SPM™ is proving to be a leading solution for overcoming the limitations of existing skin disease treatments while developing better methods and technology for cell restoration and enrichment of damaged cells.

We are currently conducting research to expand the mechanisms of action applicable to the development of cosmetics, medical devices,

and pharmaceutical products, while also pursuing registration and regulatory approval processes with relevant authorities, including the U.S. FDA.

BG PHARMACEUTICAL will continue as a global biopharmaceutical company with an endless pursuit and inspired passion.